Session 14: Practical Considerations: Counseling and Coverage of medications for Patients with Cardiometabolic and Renal disease

Wednesday, October 19, 2022, 12:30 PM - 1:45 PM, Webinar (Online)

AMA PRA Category 1 Credits™ (1.00 hours), Non-Physician (1.00 hours)

Date and Time: Session 10: Wednesday, October 19, 2022 @ 12:30pm-1:45pm PST 
Zoom Webinar ID: 976 0959 8851 
Webinar Link: https://washington.zoom.us/j/97609598851

Talk Title: Cardiovascular Implications of NAFLD/NASH: What you should know

To go back to the main course page, please click here.

Talk Objectives:

• Discuss and counsel patients on the benefits and common and rare side-effects of medications for CM and Renal disease
• Describe the mechanism to achieve coverage based on expert use and experience for the new CM and renal medications.

Accreditation with Commendation: The University of Washington School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation: The University of Washington School of Medicine designates this other for a maximum of 1.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ACPE #: 0130-9999-22-470-H01-P
0130-9999-22-470-L01-P

Dr. Arora is a board-certified Nephrologist and Internist at the University of Washington. His clinical roles include specializing in the care of patients with cardiorenal syndrome as well as serving as the clinical lead of the diabetic kidney disease clinic. Outside of his clinical responsibilities, Dr. Arora is involved in multiple educational endeavors, both traditionally and via digital education, as well as clinical research to improve the care of both patients with heart failure, as well as diabetic kidney disease. Areas of expertise: Nephrology, diabetic kidney disease, cardiorenal syndrome

Speaker Disclosure(s): none

Planner Disclosure(s):

• Dr. Nicole Ehrhardt, MD is on the Advisory board for Dexcom and Novo Nordisk; Educational Grant: Novo Nordisk and Merck; Investigator: Dexcom
• Dr. Savitha Subramanian, MD is on the advisory board for Abbott Diabetes Care and was formerly on the Advisory board for Akcea Therapeutics and Amarni.
• Laura Montour, MD: none
• Lorena Casas-Wright, MD: none
• Nayan Arora, MD: none

Mitigation of Relevant Financial Relationships

University of Washington School of Medicine adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.

Wednesday, October 19, 2022

We thank the following supporters for their educational grants: Novo Nordisk; ECHO Diabetes Action Network (EDAN)